How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

851 results for

Sudden Sensorineural Hearing Loss

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

2. Hyperbaric oxygen therapy for sudden sensorineural hearing loss

Hyperbaric oxygen therapy for sudden sensorineural hearing loss Hyperbaric oxygen therapy for sudden sensorineural hearing loss Hyperbaric oxygen therapy for sudden sensorineural hearing loss HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Hyperbaric oxygen therapy for sudden sensorineural hearing loss. Lansdale: HAYES, Inc.. Directory (...) Publication. 2016 Authors' objectives Hyperbaric oxygen therapy (HBOT) involves the intermittent inhalation of 100% gaseous oxygen in chambers pressurized between 1.5 and 3.0 times atmosphere absolute. HBOT may be used as a primary or adjunctive therapy for sudden sensorineural hearing loss (SSHL), which is a rapid loss of hearing over a period of < 72 hours. The rationale for use of HBOT in SSHL is that hearing loss may result from a hypoxic event in the cochlear apparatus, and HBOT may reverse

2017 Health Technology Assessment (HTA) Database.

3. Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss

Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss Rodríguez B, Rey-Ares L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A Record Status This is a bibliographic record of a published health technology assessment from a member (...) of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Rodríguez B, Rey-Ares L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A. Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de Evaluación de Tecnologías Sanitarias, Informe de Respuesta Rápida N° 470. 2016 Authors' conclusions Low

2016 Health Technology Assessment (HTA) Database.

4. Evaluation of cardiovascular risks and recovery of idiopathic sudden sensorineural hearing loss in hospitalised patients: comparison between complete and partial sudden sensorineural hearing loss. (PubMed)

Evaluation of cardiovascular risks and recovery of idiopathic sudden sensorineural hearing loss in hospitalised patients: comparison between complete and partial sudden sensorineural hearing loss. To evaluate the presence of cardiovascular risk factors and recovery of idiopathic sudden sensorineural hearing loss in hospitalised patients.A single-centre retrospective study of 80 patients hospitalised for idiopathic sudden sensorineural hearing loss was conducted over a 6-year period. Mean pure (...) tone hearing thresholds were assessed by pure tone audiometry.Twenty-three of 80 patients (28.75 per cent) initially had no cardiovascular risk factors. Forty-five patients had hyperlipidaemia, 22 patients had hypertension, 7 patients had diabetes mellitus and 7 patients were obese. No statistically significant difference was observed between patients with complete versus partial sudden sensorineural hearing loss (p = 0.0708) concerning the cardiovascular risk factors. At long-term follow up

2017 Journal of Laryngology & Otology

5. Use of Vasodilators In Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review.

Use of Vasodilators In Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review. To compare the effect of vasodilators with that of corticosteroids in patients with idiopathic sudden sensorineural hearing loss (ISSHL). A search in PubMed, Cochrane, and Embase was conducted. Two reviewers screened the data sources to identify articles that comply with predefined inclusion criteria. Studies that compared the therapeutic effect of vasodilators with prednisone or placebo in patients (...) with ISSHL were identified. Five articles were selected, involving a total of 611 patients. The odds ratios for perceptive hearing levels (pure tone average) post treatment varied between 0.58 and 2.18. One study demonstrated a cumulative effect (optimal hearing recovery) when vasodilators and glucocorticoids were combined (odds ratio, 1.82). Vasodilators have no beneficial effect on the treatment of ISSHL. Some evidence suggests that a combination of vasodilators with steroid treatment results in better

Full Text available with Trip Pro

2018 The journal of international advanced otology

6. The association between auditory nerve neurovascular conflict and sudden unilateral sensorineural hearing loss (PubMed)

The association between auditory nerve neurovascular conflict and sudden unilateral sensorineural hearing loss There may be an association between a neurovascular conflict (NVC) of the auditory nerve and unilateral sudden sensorineural hearing loss (SSNHL).Compression of cranial nerves by vascular structures can lead to significant symptomatology that may require surgical decompression. Notable examples are trigeminal neuralgia and hemifacial spasm. Magnetic resonance imaging (MRI) is part (...) of the workup for SSNHL, and it may depict an NVC of the auditory nerve. Here we look into the association between this NVC and unilateral SSNHL.A retrospective analysis was performed on all consecutive patients with unilateral SSNHL who underwent an MRI scan in our medical center. The data collected included age, gender, side and severity of hearing loss, and accompanying complaints. Each MRI scan was reviewed by a neuroradiologist who was unaware of hearing loss laterality. The presence, side, extent

Full Text available with Trip Pro

2018 Laryngoscope investigative otolaryngology

7. Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss (PubMed)

Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss To investigate the role of intratympanic (IT) therapy in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).This study was a retrospective review. Patients were treated for ISSNHL from January 1, 2011 to April 12, 2015 with the following: pre/posttreatment audios, treatment initiated ≤90 days and idiopathic etiology. Fifty-three ISSNHL patients were analyzed in the following subgroups

Full Text available with Trip Pro

2018 Laryngoscope investigative otolaryngology

8. Risk of sudden sensorineural hearing loss in patients with dysrhythmia: A nationwide population-based cohort study. (PubMed)

Risk of sudden sensorineural hearing loss in patients with dysrhythmia: A nationwide population-based cohort study. Whether dysrhythmia is a risk factor of sudden sensorineural hearing loss (SSNHL) remains unclear. In this study, we aimed to investigate the risk of developing SSNHL among patients with dysrhythmia in different age and gender groups by using population-based data in Taiwan.We conducted a matched cohort study by analyzing data between January 2000 and December 2013 obtained from (...) the Taiwan National Health Insurance Research Database. 41,842 newly diagnosed dysrhythmia patients and 83,684 comparison subjects without dysrhythmia were selected from claims. The incidence of sudden sensorineural hearing loss at the end of 2013 was determined in both groups. Univariate and multivariate logistic regression analyses were used to investigate the risk of SSNHL among patients with dysrhythmia.The incidence of SSNHL was 1.30-fold higher in the dysrhythmia group compared with the control

2019 PLoS ONE

9. Efficacy and tolerability of systemic versus intratympanic corticosteroid in the treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis

Efficacy and tolerability of systemic versus intratympanic corticosteroid in the treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

10. Intratympanic corticosteroid as salvage therapy in treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis

Intratympanic corticosteroid as salvage therapy in treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

11. Improvement or Recovery From Sudden Sensorineural Hearing Loss With Steroid Therapy Does Not Preclude the Need for MRI to Rule Out Vestibular Schwannoma. (PubMed)

Improvement or Recovery From Sudden Sensorineural Hearing Loss With Steroid Therapy Does Not Preclude the Need for MRI to Rule Out Vestibular Schwannoma. There is a common misconception that improvement in sudden sensorineural hearing loss (SSNHL) after treatment with steroid therapy effectively excludes the diagnosis of a vestibular schwannoma (VS) and such cases do not warrant an MRI. Paralleling this, steroids are commonly withheld for SSNHL in patients with an existing diagnosis of VS (...) to 15% in word recognition score (WRS) and/or decrease of more than or equal to 15 dB in 4-frequency pure-tone average (PTA). To supplement these data, a separate population of patients with incomplete or missing audiometric data, who reported unequivocal subjective improvement in hearing after steroid treatment, were also described to reinforce the study objective. Patient demographics, tumor characteristics, steroid regimen, and data regarding treatment response were recorded.A total of 29

2019 Otology and Neurotology

12. Predictive values of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and other prognostic factors in pediatric idiopathic sudden sensorineural hearing loss. (PubMed)

Predictive values of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and other prognostic factors in pediatric idiopathic sudden sensorineural hearing loss. No consensus has been reached regarding the optimum treatment or factors affecting prognosis in pediatric idiopathic sudden sensorineural hearing loss (ISSNHL) due to its rarity. In the present study, treatment outcomes and prognostic factors of ISSNHL were investigated in pediatric patients who underwent steroid (...) response groups differed significantly. Early treatment with steroid and accompanying tinnitus were positive prognostic factor for hearing recovery. Other characteristics were not significant.The results of this study suggest that good hearing recovery in children may be associated with early time of initial treatment and accompanying tinnitus. Also, NLR value might be useful readily accessible prognostic markers in pediatric ISSNHL patients. Further studies are required to confirm prognostic factors

2019 International Journal of Pediatric Otorhinolaryngology

13. Intratympanic Steroid Use for Sudden Sensorineural Hearing Loss: Current Otolaryngology Practice. (PubMed)

Intratympanic Steroid Use for Sudden Sensorineural Hearing Loss: Current Otolaryngology Practice. To investigate the current practice of intratympanic steroid (ITS) injection for sudden sensorineural hearing loss (SSNHL) in the United Kingdom and link the data with data from the United States and continental Europe.A survey of 21 questions was distributed to members of the British Society of Otology using an online survey platform via ENT UK. Data obtained from UK otolaryngologists (n = 171 (...) has failed, and similar results are found in the continental Europe and US surveys. The most commonly used preparation is dexamethasone. Responses to questions regarding treatment regimes used are enlightening and show considerable variation in the treatment regimes used within and between countries.There is a wide variation in practice with regards to ITS for SSNHL hearing loss in the United Kingdom, United States, and continental Europe. In the absence of protocols or definitive guidance from

2019 Rhinology and Laryngology

14. Association between mitral valve prolapse and sudden sensorineural hearing loss: A case-control population-based study. (PubMed)

Association between mitral valve prolapse and sudden sensorineural hearing loss: A case-control population-based study. This study aimed to evaluate the relationship between sudden sensorineural hearing loss (SSNHL) and MVP using a population-based dataset. Data for this case-control study were retrieved from the Taiwan Longitudinal Health Insurance Database. In total, 3399 cases of newly diagnosed SSNHL were identified. We used propensity score matching to select 3399 comparison patients (one

Full Text available with Trip Pro

2018 PLoS ONE

15. Inflammatory cytokines and mononuclear cells in sudden sensorineural hearing loss. (PubMed)

Inflammatory cytokines and mononuclear cells in sudden sensorineural hearing loss. This study evaluated tumour necrosis factor-α, interleukins 10 and 12, and interferon-γ levels, peripheral blood mononuclear cells, and clusters of differentiation 17c and 86 expression in unilateral sudden sensorineural hearing loss.Twenty-four patients with unilateral sudden sensorineural hearing loss, and 24 individuals with normal hearing and no history of sudden sensorineural hearing loss (who were attending (...) to the control group. However, interferon-γ and interleukin 12 levels were significantly decreased. The difference in mean interleukin 10 level was not significant.Increases in tumour necrosis factor-α level and monocyte population might play critical roles in sudden sensorineural hearing loss. This warrants detailed investigation and further studies on the role of dendritic cells in sudden sensorineural hearing loss.

2019 Journal of Laryngology & Otology

16. Acupuncture for the treatment of sudden sensorineural hearing loss: A systematic review and meta-analysis: Acupuncture for SSNHL. (PubMed)

Acupuncture for the treatment of sudden sensorineural hearing loss: A systematic review and meta-analysis: Acupuncture for SSNHL. Acupuncture as an alternative treatment method is widely used in the treatment of sudden sensorineural hearing loss(SSNHL) in China. We performed a systematic review and meta-analysis to assess the clinical efficacy of acupuncture for the management of SSNHL patients.The PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure and WanFang databases

2019 Complementary Therapies In Medicine

17. Hormone therapy is not associated with the risk of sudden sensorineural hearing loss in postmenopausal women: a 10-year nationwide population-based study. (PubMed)

Hormone therapy is not associated with the risk of sudden sensorineural hearing loss in postmenopausal women: a 10-year nationwide population-based study. The association between hormone therapy (HT) and the risk for sudden sensorineural hearing loss (SSNHL) in postmenopausal women has been described only in case reports. No large study has further evaluated the association between HT and the risk of SSNHL in postmenopausal women. The objective of our study was to investigate whether

2019 Menopause

18. Effects of meteorological factor and air pollution on sudden sensorineural hearing loss using the health claims data in Busan, Republic of Korea. (PubMed)

Effects of meteorological factor and air pollution on sudden sensorineural hearing loss using the health claims data in Busan, Republic of Korea. Specific meteorological factors, including air pollution in the form of particulate matter (PM), affect the development of otologic disease and have adverse effects on the cardiovascular and respiratory systems. This study investigated relationships between the development of sudden sensorineural hearing loss(SSNHL) and meteorological factor with air

2019 American Journal of Otolaryngology

19. Improvement or Recovery From Sudden Sensorineural Hearing Loss With Steroid Therapy Does Not Preclude the Need for MRI to Rule Out Vestibular Schwannoma. (PubMed)

Improvement or Recovery From Sudden Sensorineural Hearing Loss With Steroid Therapy Does Not Preclude the Need for MRI to Rule Out Vestibular Schwannoma. There is a common misconception that improvement in sudden sensorineural hearing loss (SSNHL) after treatment with steroid therapy effectively excludes the diagnosis of a vestibular schwannoma (VS) and such cases do not warrant an MRI. Paralleling this, steroids are commonly withheld for SSNHL in patients with an existing diagnosis of VS (...) to 15% in word recognition score (WRS) and/or decrease of more than or equal to 15 dB in 4-frequency pure-tone average (PTA). To supplement these data, a separate population of patients with incomplete or missing audiometric data, who reported unequivocal subjective improvement in hearing after steroid treatment, were also described to reinforce the study objective. Patient demographics, tumor characteristics, steroid regimen, and data regarding treatment response were recorded.A total of 29

2019 Otology and Neurotology

20. An unusual case of sudden sensorineural hearing loss after cycling class. (PubMed)

An unusual case of sudden sensorineural hearing loss after cycling class. In this case report, our patient developed sudden sensorineural hearing loss (SSNHL) after loud noise exposure during a popular cardiovascular group exercise cycling class. To increase awareness among all healthcare professionals of the effects of these modern-day group fitness classes on hearing loss, we describe this case and review the current literature on SSNHL and its management. A 35-year old man developed SSNHL (...) in the setting of loud noise exposure during a high intensity aerobic exercise class. After a short course of oral steroids with no improvement, intratympanic steroids were administered weekly for three weeks. The patient showed minimal improvement; thus, hyperbaric oxygen therapy was conducted. Serial audiograms continued to show severe to profound mixed hearing loss in the right ear. In conclusion, individuals who participate in loud, high-intensity aerobic group-exercise classes should be careful

2019 American Journal of Otolaryngology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>